If we build it they will come: targeting the immune response to breast cancer

Historically, breast cancer tumors have been considered immunologically quiescent, with the majority of tumors demonstrating low lymphocyte infiltration, low mutational burden, and modest objective response rates to anti-PD-1/PD-L1 monotherapy. Tumor and immunologic profiling has shed light on poten...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :NPJ Breast Cancer
Главные авторы: Gatti-Mays, Margaret E., Balko, Justin M., Gameiro, Sofia R., Bear, Harry D., Prabhakaran, Sangeetha, Fukui, Jami, Disis, Mary L., Nanda, Rita, Gulley, James L., Kalinsky, Kevin, Abdul Sater, Houssein, Sparano, Joseph A., Cescon, David, Page, David B., McArthur, Heather, Adams, Sylvia, Mittendorf, Elizabeth A.
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group UK 2019
Предметы:
Review Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6820540/
https://ncbi.nlm.nih.gov/pubmed/31700993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-019-0133-7
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы